Cabozantinib: tested on its own
98 studies: no other medicine in its arm. Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination TherapyNot yet recruitingNCT07151326Phase 2Report a problem
- Cabozantinib Dose Skipping as an Alternative to Dose ReductionsRecruitingNCT07077161Phase 2Report a problem
- A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and BevacizumabNot yet recruitingNCT06535737Phase 2Report a problem
- Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerRecruitingNCT06475989Phase 3Report a problem
- Cabozantinib With Ifosfamide in Relapsed/Refractory SarcomasRecruitingNCT06156410Phase 1Report a problem
- Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)RecruitingNCT05931393Phase 2Report a problem
- Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT05613894Phase 1Report a problem
- Cabozantinib for Patients With Recurrent or Progressive MeningiomaRecruitingNCT05425004Phase 2Report a problem
- Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied PatientsNot yet recruitingNCT05241561Phase 2Report a problem
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsRecruitingNCT05135975Phase 2Report a problem
- Cabozantinib to Treat Recurrent Liver Cancer Post TransplantRecruitingNCT04204850Phase 2Report a problem
- Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityRecruitingNCT01639508Phase 2Report a problem
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaTerminatedNCT06341712Phase 2Results postedReport a problem
- Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)TerminatedNCT04631744Phase 2Results postedReport a problem
- Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line TherapyTerminatedNCT04497038Phase 1/2Results postedReport a problem
- Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION)CompletedNCT04316182Phase 2Results postedReport a problem
- Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the ExtremitiesTerminatedNCT04220229Phase 1/2Results postedReport a problem
- Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment FailureCompletedNCT04205799Phase 2Results postedReport a problem
- Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney CancerActive, not recruitingNCT04022343Phase 2Results postedReport a problem
- Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate CancerTerminatedNCT03964337Phase 2Results postedReport a problem
- Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint InhibitorsCompletedNCT03945773Phase 2Results postedReport a problem
- A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyActive, not recruitingNCT03690388Phase 3Results postedReport a problem
- A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular CarcinomaCompletedNCT03586973Phase 2Results postedReport a problem
- Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal CancerCompletedNCT03542877Phase 2Results postedReport a problem
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsActive, not recruitingNCT03375320Phase 3Results postedReport a problem
- Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaCompletedNCT03370718Phase 2Results postedReport a problem
- A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell CarcinomaCompletedNCT03339219Phase 2Results postedReport a problem
- Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaTerminatedNCT03201250Phase 1/2Results postedReport a problem
- Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in ChildrenTerminatedNCT02885324Phase 2Results postedReport a problem
- Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsActive, not recruitingNCT02867592Phase 2Results postedReport a problem
- Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02315430Phase 2Results postedReport a problem
- Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by SurgeryCompletedNCT02302833Phase 2Results postedReport a problem
- Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing SarcomaActive, not recruitingNCT02243605Phase 2Results postedReport a problem
- Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain MetastasesTerminatedNCT02132598Phase 2Results postedReport a problem
- Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and AdultsCompletedNCT02101736Phase 2Results postedReport a problem
- Cabozantinib in Recurrent/Metastatic Merkel Cell CarcinomaTerminatedNCT02036476Phase 2Results postedReport a problem
- Cabozantinib (XL-184) Monotherapy for Advanced CholangiocarcinomaCompletedNCT01954745Phase 2Results postedReport a problem
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerCompletedNCT01935934Phase 2Results postedReport a problem
- Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior SorafenibCompletedNCT01908426Phase 3Results postedReport a problem
- A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid CancerActive, not recruitingNCT01896479Phase 4Results postedReport a problem
- Cabozantinib (XL184) in Patients With Relapsed or Refractory MyelomaCompletedNCT01866293Phase 1/2Results postedReport a problem
- A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell CarcinomaCompletedNCT01865747Phase 3Results postedReport a problem
- A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral MetastasesCompletedNCT01834651Phase 2Results postedReport a problem
- Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusCompletedNCT01822522Phase 1Results postedReport a problem
- Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate CancerCompletedNCT01812668Not applicableResults postedReport a problem
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid CancerCompletedNCT01811212Phase 2Results postedReport a problem
- Cabozantinib for Adults With Advanced Soft Tissue SarcomaCompletedNCT01755195Phase 2Results postedReport a problem
- Cabozantinib for Metastatic Triple Negative BrCaCompletedNCT01738438Phase 2Results postedReport a problem
- Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsCompletedNCT01709435Phase 1Results postedReport a problem
- Cabozantinib in Men With Castration-Resistant Prostate CancerTerminatedNCT01703065Phase 2Results postedReport a problem
- Cabozantinib for Advanced Urothelial CancerCompletedNCT01688999Phase 2Results postedReport a problem
- Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100CompletedNCT01605227Phase 3Results postedReport a problem
- Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate CancerCompletedNCT01599793Phase 2Results postedReport a problem
- Cabozantinib in Advanced Solid MalignanciesCompletedNCT01588821Phase 2Results postedReport a problem
- Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerTerminatedNCT01522443Phase 3Results postedReport a problem
- Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid TumorsCompletedNCT01466036Phase 2Results postedReport a problem
- Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to BoneTerminatedNCT01428219Phase 2Results postedReport a problem
- Cabozantinib (XL184) in Men With Castrate-Resistant Prostate CancerCompletedNCT01347788Phase 1Results postedReport a problem
- Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseTerminatedNCT01068782Phase 2Results postedReport a problem
- Study of Cabozantinib (XL184) in Adults With Advanced MalignanciesCompletedNCT00940225Phase 2Results postedReport a problem
- Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid CancerCompletedNCT00704730Phase 3Results postedReport a problem
- Study of XL184 (Cabozantinib) in Adults With Glioblastoma MultiformeCompletedNCT00704288Phase 2Results postedReport a problem
- Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells CancerTerminatedNCT06377722Phase 2Report a problem
- caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.Active, not recruitingNCT06171854Phase 2Report a problem
- Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.CompletedNCT05660954Phase 2Report a problem
- Multiparametric Assessment of Bone Response in mCRPC Patients Treated With CabozantinibCompletedNCT05265988Phase 2Report a problem
- The Pharmacological Effects of Using Cabozantinib With a Light BreakfastCompletedNCT05263245Phase 2Report a problem
- A Phase II Trial of Cabozantinib With Patients With Refractory GCTsCompletedNCT04876456Phase 2Report a problem
- Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 InhibitorsCompletedNCT04767906Phase 2Report a problem
- Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell CarcinomaStatus unknownNCT04714697Phase 2Report a problem
- Cabozantinib in Hepatocellular CarcinomaActive, not recruitingNCT04588051Phase 2Report a problem
- A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3Active, not recruitingNCT04524208Phase 2Report a problem
- Dose Escalation Study of Cabozantinib for Advanced HCC Patients with Preserved Liver FunctionCompletedNCT04522908Phase 2Report a problem
- Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line TreatmentCompletedNCT04511455Phase 2Report a problem
- A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver FunctionStatus unknownNCT04454762Phase 2Report a problem
- Efficacy and Safety of Cabozantinib in Patients With Hepatocellular CarcinomaStatus unknownNCT04435977Phase 2Report a problem
- Cabozantinib in High Grade Neuroendocrine NeoplasmsActive, not recruitingNCT04412629Phase 2Report a problem
- Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR StudyCompletedNCT04134390Phase 2Report a problem
- Phase II Study With Cabozantinib in Patients With RET Positive NSCLCStatus unknownNCT04131543Phase 2Report a problem
- Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.TerminatedNCT04066595Phase 2Report a problem
- Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain MetastasesCompletedNCT03967522Phase 2Report a problem
- Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)CompletedNCT03963206Phase 4Report a problem
- Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)Status unknownNCT03943602Phase 2Report a problem
- CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET DeregulationStatus unknownNCT03911193Phase 2Report a problem
- Cabozantinib in Advanced Salivary Gland Cancer PatientsTerminatedNCT03729297Phase 2Report a problem
- ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)CompletedNCT03685448Phase 2Report a problem
- A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaCompletedNCT03463681Phase 2Report a problem
- caBozantinib in cOllectiNg ductS Renal Cell cArcInomaCompletedNCT03354884Phase 2Report a problem
- Ph II CABOGIST in GISTCompletedNCT02216578Phase 2Report a problem
- A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line SettingStatus unknownNCT02041260Phase 2Report a problem
- IRCI Gynae Sarcomas, High Grade Uterine SarcomaCompletedNCT01979393Phase 2Report a problem
- Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01961765Phase 1Report a problem
- A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal FunctionCompletedNCT01761773Phase 1Report a problem
- XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone DiseaseCompletedNCT01582295Phase 1Report a problem
- Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced CancerCompletedNCT01553656Phase 1Report a problem
- Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult SubjectsCompletedNCT01493869Phase 1Report a problem
- Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in JapanCompletedNCT01018745Phase 1Report a problem
- Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesCompletedNCT00215605Phase 1Report a problem